HIGH

CVE-2023-38952

CVSS v3

7.5

HIGH

EPSS Score

16.2%

exploit probability

CISA KEV

No

known exploited

Exploitation

SSVC status

Description

Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.

Technical details

Published
8/3/2023

Frequently asked questions

What is CVE-2023-38952?

Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.

Is CVE-2023-38952 actively exploited?

Active exploitation of CVE-2023-38952 has not been confirmed. The EPSS score is 16.2%, indicating the estimated probability of exploitation in the next 30 days.

What is the CVSS score for CVE-2023-38952?

CVE-2023-38952 has a CVSS v3 base score of 7.5 (HIGH severity).

Is CVE-2023-38952 affecting your environment?

Use isMalicious to check if any of your IPs or domains are associated with this vulnerability's IOCs.